Risk factors of trastuzumab-induced cardiotoxicity in breast cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference42 articles.
1. LVAD: left ventricular assist devices for end-stage heart failure;Laing;Nurse Pract,2014
2. Early breast cancer therapy and cardiovascular injury;Jones;J Am Coll Cardiol,2007
3. Anthracycline cardiotoxicity: from bench to bedside;Gianni;J Clin Oncol,2008
4. Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer;Tsang;Br J Cancer,2012
5. Detection of early sub-clinical trastuzumab-induced cardiotoxicity in breast cancer patients;Dores;Arq Bras Cardiol,2013
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab;Cardio-Oncology;2024-05-29
2. Cardiovascular outcomes associated with SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cancer: a systematic review and meta-analysis;Diabetology & Metabolic Syndrome;2024-05-22
3. Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis;Revista Portuguesa de Cardiologia;2023-12
4. Compensatory role of neuregulin-1 in diabetic cardiomyopathy;Journal of Pharmacological Sciences;2023-11
5. Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment;Frontiers in Pharmacology;2023-09-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3